アクセプト論文 2020年

Elevated serum levels of checkpoint molecules in patients with adult Still's disease

筆者 Fujita Y, Asano T, Matsumoto H, Matsuoka N, Temmoku J, Sato S, Furuya MY, Suzuki E, Watanabe H, Koga T, Kawakami A, Migita K.
掲載誌 Arthritis Res Ther. 2020 Jul 22;22(1):174.

Primary Sjögren's Syndrome Accompanied by Clinical Features of TAFRO Syndrome

筆者 Suzuki E, Ichimura T, Kimura S, Kanno T, Migita K.
掲載誌 Case Rep Rheumatol. 2020 Sep 17;2020:8872774.

IgG4-Related Disease Complicated by Brain Parenchymal Lesions Successfully Treated with Corticosteroid Therapy: A Case Report

筆者 Temmoku J, Sato S, Matsumoto H, Fujita Y, Suzuki E, Yashiro-Furuya M, Matsuoka N, Asano T, Ito E, Nakatani-Enomoto S, Kobayashi H, Watanabe H, Hashimoto Y, Migita K.
掲載誌 Tohoku J Exp Med. 2020 Jul;251(3):161-168.

Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus

筆者 Asano T, Matsuoka N, Fujita Y, Matsumoto H, Temmoku J, Yashiro-Furuya M, Sato S, Suzuki E, Kobayashi H, Watanabe H, Migita K.
掲載誌 J Clin Med. 2020 Nov 5;9(11):3563.

Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis

筆者 Migita K, Nakamura M, Aiba Y, Kozuru H, Abiru S, Komori A, Fujita Y, Temmoku J, Asano T, Sato S, Furuya M, Naganuma A, Yoshizawa K, Shimada M, Ario K, Mannami T, Kohno H, Kaneyoshi T, Komura T, Ohira H, Yatsuhashi H.
掲載誌 PLoS One. 2020 Dec 21;15(12):e0238540.

[A case of ferroportin disease with phenotype A gene mutation in SCL40A1 resembling phenotype B manifestation influenced by alcohol consumption]

筆者 Matsuoka N, Hayashi M, Takahashi Y, Mochimaru T, Kumakawa H, Watanabe K, Tatsumi Y, Kato K, Ikuta K, Migita K, Ohira H.
掲載誌 Nihon Shokakibyo Gakkai Zasshi. 2020;117(12):1100-1108

T cell immunoglobulin and mucin domain-3 is associated with disease activity and progressive joint damage in rheumatoid arthritis patients

筆者 Matsumoto H, Fujita Y, Asano T, Matsuoka N, Temmoku J, Sato S, Yashiro-Furuya M, Watanabe H, Migita K.
掲載誌 Medicine (Baltimore). 2020 Oct 30;99(44):e22892.

The possession of exon 2 or exon 3 variants in the MEFV gene promotes inflammasome activation in Japanese patients with familial Mediterranean fever with a heterozygous exon 10 mutation

筆者 Endo Y, Koga T, Hara K, Furakawa K, Agematsu K, Yachie A, Masumoto J, Migita K, Kawakami A.
掲載誌 Clin Exp Rheumatol. 2020 Sep-Oct;38 Suppl 127(5):49-52.

Next-generation sequencing of the whole MEFV gene in Japanese patients with familial Mediterranean fever: a case-control association study

筆者 Koga T, Sato S, Mishima H, Migita K, Endo Y, Umeda M, Sumiyoshi R, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A.
掲載誌 Clin Exp Rheumatol. 2020 Sep-Oct;38 Suppl 127(5):35-41.

KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle-Wells syndrome

筆者 Kaneko N, Kurata M, Yamamoto T, Shigemura T, Agematsu K, Yamazaki T, Takeda H, Sawasaki T, Koga T, Kawakami A, Yachie A, Migita K, Yoshiura KI, Urano T, Masumoto J.
掲載誌 Sci Rep. 2020 Aug 11;10(1):13562.

Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis

筆者 Yamashita K, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Okiyama N, Nagaoka S, Shimada K, Sugii S, Katayama M, Hirohata S, Okamoto A, Chiba N, Suematsu E, Setoguchi K, Migita K, Sumida T, Tohma S, Hamaguchi Y, Hasegawa M, Sato S, Kawaguchi Y, Takehara K, Tsuchiya N.
掲載誌 heumatology (Oxford). 2020 Nov 1;59(11):3553-3562.

Clinical phenotypes and genetic analyses for diagnosis of systemic autoinflammatory diseases in adult patients with unexplained fever

筆者 Hidaka Y, Fujimoto K, Matsuo N, Koga T, Kaieda S, Yamasaki S, Nakashima M, Migita K, Nakayama M, Ohara O, Hoshino T, Nishikomori R, Ida H.
掲載誌 Mod Rheumatol. 2020 Jul 24:1-6.

Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis

筆者 Ueno K, Aiba Y, Hitomi Y, Shimoda S, Nakamura H, Gervais O, Kawai Y, Kawashima M, Nishida N, Kohn SS, Kojima K, Katsushima S, Naganuma A, Sugi K, Komatsu T, Mannami T, Matsushita K, Yoshizawa K, Makita F, Nikami T, Nishimura H, Kouno H, Kouno H, Ohta H, Komura T, Tsuruta S, Yamauchi K, Kobata T, Kitasato A, Kuroki T, Abiru S, Nagaoka S, Komori A, Yatsuhashi H, Migita K, Ohira H, Tanaka A, Takikawa H, Nagasaki M, Tokunaga K, Nakamura M; PBC‐GWAS Consortium in Japan.
掲載誌 Hepatol Commun. 2020 Mar 15;4(5):724-738.

Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis

筆者 Koga T, Sumiyoshi R, Furukawa K, Sato S, Migita K, Shimizu T, Umeda M, Endo Y, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nonaka F, Yachie A, Kondo H, Maeda T, Kawakami A.
掲載誌 Arthritis Res Ther. 2020 May 7;22(1):108.

Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case-Control Study

筆者 Furukawa H, Oka S, Shimada K, Okamoto A, Hashimoto A, Komiya A, Saisho K, Yoshikawa N, Katayama M, Matsui T, Fukui N, Migita K, Tohma S.
掲載誌 Front Med (Lausanne). 2020 Dec 17;7:599794.

Familial Mediterranean fever phenotype progression into anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis: a case report

筆者 Yago T, Asano T, Fujita Y, Migita K.
掲載誌 Fukushima J Med Sci. 2020 Dec 10;66(3):160-166.

JAK Inhibitors Impair GM-CSF-mediated Signaling in Innate Immune Cells.

筆者 Fujita Y, Matsuoka N, Temmoku J, Furuya-Yashiro M, Asano T, Sato S, Matsumoto H, Watanabe H, Kozuru H, Yatsuhashi H, Kawakami A, Migita K.
掲載誌 BMC Immunol. 2020 Jun 15;21(1):35.

An autopsy case of mixed connective tissue disease complicated by thrombotic thrombocytopenic purpura.

筆者 Furuya-Yashiro M, Watanabe H, Sato S, Fujita Y, Tenmoku J, Matsuoka N, Asano T, Suzuki E, Kobayashi H, Migita K.
掲載誌 Intern Med. 2020;59(10):1315-1321.

Efficacy of tofacitinib for slowly progressive interstitial lung disease in a patient with anti-MDA5 antibody-positive dermatomyositis.

筆者 Takatani A, Koga T, Fujita Y, Fukui S, Endo Y, Shimizu T, Kawakami A.
掲載誌 Clin Immunol. 2020 Apr 29;215:108451. doi: 10.1016/j.clim.2020. 108451. Online ahead of print.

Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients.

筆者 Fujita Y, Asano T, Matsuoka N, Temmoku J, Sato S, Matsumoto H, Furuya MY, Suzuki E, Watanabe H, Kawakami A, Migita K.
掲載誌 Arthritis Res Ther. 2020 Apr 15;22(1):80.

Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis.

筆者 Sato S, Zhang XK, Temmoku J, Fujita Y, Matsuoka N, Yashiro-Furuya M, Asano T, Kobayashi H, Watanabe H, Migita K.
掲載誌 Cells. 2020 Mar 14;9(3). pii: E714.

Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers.

筆者 Sato S, Temmoku J, Fujita Y, Yashiro-Furuya M, Matsuoka N, Asano T, Kobayashi H, Watanabe H, Migita K.
掲載誌 Fukushima J Med Sci. 2020 Mar 13.

Uric acid-mediated inflammasome activation in IL-6 primed innate immune cells is regulated by baricitinib.

筆者 Temmoku J, Fujita Y, Matsuoka N, Urano T, Furuya MY, Asano T, Sato S, Matsumoto H, Watanabe H, Kozuru H, Yatsuhashi H, Kawakami A, Migita K.
掲載誌 Mod Rheumatol. 2020 Mar 9:1-20.

Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports.

筆者 Asano T, Sato S, Temmoku J, Fujita Y, Furuya MY, Matsuoka N, Kobayashi H, Suzuki E, Watanabe H, Migita K.
掲載誌 Medicine (Baltimore). 2020 Jan;99(4):e18890.

A case of dermatomyositis complicated with pleural effusion and massive ascites.

筆者 Matsuoka N, Asano T, Sato S, Sasajima T, Fujita Y, Temmoku J, Yashiro Furuya M, Matsumoto H, Suzuki E, Kobayashi H, Watanabe H, Migita K.
掲載誌 Fukushima J Med Sci. 2020 Jan 9;65(3):140-145.

Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.

筆者 Matsuoka N, Fujita Y, Temmoku J, Furuya MY, Asano T, Sato S, Matsumoto H, Kobayashi H, Watanabe H, Suzuki E, Kozuru H, Yastuhashi H, Migita K.
掲載誌 PLoS One. 2020 Jan 27;15(1):e0227069.

ページの先頭へ戻る